Overview

Vasopressin Effects on Human Social Communication

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This research is being done because we wish to understand how a chemical produced in the brain, vasopressin, effects emotional social communication processes. Understanding how this system works in normal individuals may help us understand why some people, particularly those with autism and/or antisocial personality disorder, have dysfunctional social interactions. This study will test the effects of 3 doses of arginine vasopressin, delivered intranasally, on physiological and behavioral responses to the faces of same- and other-sex individuals in healthy men and women.
Phase:
Phase 1
Details
Lead Sponsor:
Bowdoin College
Collaborators:
Maine Medical Center
MaineHealth
National Institute of Mental Health (NIMH)
Treatments:
Arginine Vasopressin
Vasopressins